Page 10 - Lifesci Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts

Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Corey davisNatalie badilloEndocrine societyCrinetics pharmaceuticals announces earlyExchange commissionLifesci advisorsSecurities exchangeCrinetics pharmaceuticalsHead of corporate communicationsCrinetics pharmaceuticals incPharmaceuticals announces early releaseCongenital adrenal hyperplasiaLate breaking poster presentationSecurities actSecurities exchange actSci advisors

MediWound to Report First Quarter 2024 Financial Results

Conference Call and Webcast Scheduled for Wednesday, May 29th at 8:30 am Eastern Time.

Hani luxenburgKellie hansonLifesci advisorsMediwound ltdEastern timeWound contactsSci advisors

89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress

89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoUniversity of california san diegoHank mansbachAnnie changArunj sanyalSheryl seapyRohit loombaLifesci advisorsDivision of gastroenterologyInternational liver congressVirginia commonwealth universityExchange commissionDrug administrationWeek dataPegozafermin trial

Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024

Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesBrian ritchieQueen mary university londonPrader willi syndrome association united statesPhd barts healthSoleno therapeutics incLifesci advisorsMeeting of the endocrine societyFoundation for prader willi researchTherapeutics announces oral presentationDiazoxide cholineExtended release tabletsPrader willi syndromeAnnual meetingEndocrine societyExtended release tablets worsens hyperphagia

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

WINSTON-SALEM, N.C., May 21, 2024 ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , will host a virtual KOL event on Tuesday, May.

United statesArnoldl silvaEthan holdawayUniversity of arizonaTranslational researchLifesci advisorsCompany classProkidney corpIcahn school of medicine at mount sinaiEuropean renal associationDivision of nephrologyUniversity of californiaCalifornia state universityDepartment of internal medicineExchange commissionAmerican society of nephrology